Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Axitinib (ATC-Code: L01EK01).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount contract for the active substance Axitinib (ATC-Code: L01EK01) under § 130a Abs. 8 SGB V.
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per § 4 Abs. 18 AMG.
- Contracts are non-exclusive and follow an 'open-house-model' with uniform conditions.
- Submission of contract documents by 28.05.2025 for the 01.07.2025 start date.
Key facts
- Contract period
- Up to 24 months, ending no later than 30.06.2027.
- Evaluation
- This is not a public procurement tender, so standard evaluation methods do not apply.
What it takes to qualify
Worth a closer look
- The tender document states it is not a public procurement contract in the sense of Directive 2014/24/EU.
- The publication is for transparency and uses the 'offenes Verfahren' terminology due to the publication form, not for submission under procurement law.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
- Being a pharmaceutical entrepreneur with a seat in the AMG area, EU, or EEA.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documentsTo be requested from AOK Niedersachsen and submitted by the deadline.